Sangam Health Care Products Ltd announced the appointment of S Vijayagowri Satyabhavani as Chief Financial Officer (CFO), effective February 24, 2026. The move follows the resignation of outgoing CFO Satish Kumar Varre. The leadership change is expected to strengthen the company’s financial management and support its long-term growth strategy.
Sangam Health Care Products Ltd confirmed a key leadership transition in its finance division. The company announced that S Vijayagowri Satyabhavani has been appointed as Chief Financial Officer (CFO), effective February 24, 2026. This appointment comes after the resignation of Satish Kumar Varre, who previously held the position.
Key Highlights
-
S Vijayagowri Satyabhavani appointed as CFO of Sangam Health Care Products Ltd
-
Appointment effective from February 24, 2026
-
Outgoing CFO Satish Kumar Varre resigns from the role
-
Leadership change expected to enhance financial oversight and governance
-
Company reiterates commitment to strengthening financial management and growth
Strategic Impact
The appointment of a new CFO marks an important step for Sangam Health Care Products Ltd as it continues to expand in the healthcare sector. Analysts note that strong financial leadership is critical for managing growth, ensuring compliance, and driving operational efficiency. The transition is expected to provide continuity while reinforcing the company’s focus on long-term strategic goals.
Sources: Reuters, Economic Times, Business Standard